Aviva to make £81 million PMI rebate

Part of Covid-19 pledge

John Brazier
clock • 1 min read

Aviva has announced it is to pay back £81 million to private health insurance policyholders as part of its pledge on delayed treatments and procedures due to Covid-19.

The provider previously extended this pledge to the end of 2022 and increased payment levels by 20% in October last year. First announced in May 2020, Aviva pledged to promise to return any difference to policyholders should PMI claims be lower than planned over the duration of the pandemic due to the restricted availability of private medical treatment. Now Aviva confirmed that it will refund a total of £81m to PMI policyholders relating to its estimate of the difference between expected claims costs and actual claims costs for the period of claims monitored - from 1 March 2020 to 31...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on PMI

Cancer, mental health and MSK top RedArc referrals
PMI

Cancer, mental health and MSK top RedArc referrals

Represent 51% of the conditions over the past five years

Jaskeet Briah
clock 10 March 2026 • 2 min read
Young adults 'most open' to exploring private healthcare
PMI

Young adults 'most open' to exploring private healthcare

Younger adults 'redefining' what they expect from healthcare

Jaskeet Briah
clock 06 March 2026 • 2 min read
Private healthcare admissions hit record in Q3 2025
PMI

Private healthcare admissions hit record in Q3 2025

PMI paid admissions at a record level

Jaskeet Briah
clock 03 March 2026 • 2 min read